ArticleVaccine2023

Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.

Haitao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.